Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mikasa Pharmaceutical is a Japanese specialty pharmaceutical company that focuses on the development, manufacturing, and sale of external preparations, specifically transdermal patches and topical analgesics. Established in 1945 and based in Tokyo, the company has built a strong reputation in the field of pain management and anti-inflammatory medication. Its product line includes well-known treatments for orthopedic conditions such as osteoarthritis, rheumatoid arthritis, and muscular pain, utilizing active ingredients like felbinac and ketoprofen. Mikasa maintains advanced manufacturing capabilities at its Kakegawa plant, ensuring high-quality production of patches, ointments, and gels. The company continues to innovate in drug delivery systems to improve the efficacy and convenience of topical treatments for patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mikasa Pharmaceutical.